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A regio- and stereoselective approach to fluorinated (3-aminocyclohcxcnc or cyclohexane esters has 
been developed, starting from a bicyclic P-lactam (1). The procedure involves six or seven steps, based 
on regio- and stereoselective iodolactonization. lactone opening and hydroxy-fluorine exchange. The 
method has been extended to the synthesis of fluorinated amino ester enantiomers.
Introduction Results and discussion
Introduction of fluorine, thanks to its unique properties, into 
organic molecules has become a very attractive area of synthetic 
and medicinal chemistry. Although fluorine is virtually absent 
in biologically active natural products, its presence in many 
compounds with important pharmacological properties, e.g. drugs 
and agrochemicals, has led to an enormous increase in fluorine 
interest in organic chemistry in the past 20 years. The role of 
fluorine in medicinal chemistry and drug design is reflected in 
the increasing number of fluorine-containing drugs on the market 
(more than 20%). Based on a score of unique characteristics of 
the fluorine atom (small stcric size and high electronegativity) 
and of the C -F  bond (high bond energy and low polarizability), 
introduction of a fluorine atom into an organic molecule generates 
a series o f changes in properties such as polar hydrophobicity, high 
dipole moment and effects on basicity reactivity and metabolic 
stability. Moreover, the introduction o f one or more fluorine atoms 
into biologically active molecules may generate profound and 
remarkable changes in their biological properties.1
Among the large family of bioactive fluorinated compounds, 
fluorinated amino acids2 and peptides5 are of value in medicinal 
chemistry as enzyme inhibitors, antitum our agents and antibiotics. 
Owing to the special characteristics o f fluorine, the chemistry 
of fluorinated cyclic amino acids is a very interesting area. In 
spite of the great potential o f cyclic amino acids, only few cyclic 
fluorinated derivatives have been reported so far. among either 
a-am ino acids23,4 or y-amino acids (conformationally restricted 
fluorinated GABA analogues).23,5
Furthermore, although cyclic P-amino acids have recently 
generated increasing interest,6 somewhat surprisingly for us, only 
few fluorinated cyclic p-amino acids have been synthesized so 
far.2f'7
Our present aim was to develop a stereo- and regios- 
elective synthetic route to mono- and difluorinated P- 
aminocyclohexancarboxylates. The stereo- and regioselective in­
troduction o f a fluorine atom onto the cycloalkane skeleton of a p- 
amino acid was accomplished by selective hydroxylation, followed 
by hydroxy-fluorine exchange, using either diethylaminosulfur 
trifluoride (DAST) or bis(2-methoxyethyl)aminosulfur trifluoride 
(Deoxofluor) as fluorinating agent (Scheme 1). A hydroxy function 
was stereo- and regioselectively introduced onto the skeleton of an 
alicyclic P-amino acid, with selective iodolactonization as key step. 
The unsaturated cyclic N-Boc-protecled amino acid 2. obtained 
from bicyclic P-lactam 1 was subjected to iodolactonization in the 
presence of K I/I ; in a slightly alkaline medium, to furnish lactone 







Scheme 1 Retrosynthetic scheme for the regio- and stereoselective 
synthesis of fluorinated p-amino esters.
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Scheme 2 Synthesis of hydroxylated p-amino ester diastereoisomers 5 
and 6.
Subsequently, base-mediated dehydroiodination of iodolactone 
3 in the presence of DBU in refluxing TH F afforded unsaturated 
lactone 4. Lactone ring-opening with NaOEt in EtOH at 0 °C 
for 1 h furnished the «//-m-hydroxylatcd p-amino ester 5 in 
75% yield. The similar transformation of 4 at 20 °C for 9 h



































resulted in epimerization at C -l. to alTord 6. a diastereoisomcr 
of 5 (Scheme 2).
Diastereoisomers 5 and 6 were next subjected to fluorination 
based on hydroxy-fluorine exchange methodology, with the use 
of DAST or Dcoxofluor. When treated with DAST in CTTC12 at 
0 °C, 5 gave an oily mixture of two fluorinated products (T1 and 
T2) in approximately 1 : 1 ratio ('H -N M R spectroscopy), which 
could not be separated by flash chromatography.
Catalytic hydrogenation of this mixture in EtOAc and column 
chromatographic separation of the products on silica gel with n- 
hexane-EtOAc 9: 1 as eluent furnished two (3-aminocarboxylate 
diastereoisomers (7 and 8), with the fluorine atom on position 5 
of the cyclohexane ring (Scheme 3). The structures o f 7 and 8 were 
determined by 2D NM R and X-ray analysis (Fig. 1).
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Scheme 3 Synthesis of fluorinated p-amino esters 7 and 8.
Fig. 1 ORTEP diagram of 7.
These experimental results suggested that, in contrast with the 
generally observed SN2 mechanism of hydroxy-fluorine exchange, 
5 undergoes an allylic rearrangement to T4 in the presence of 
DAST followed by fluoride attack at C-5 through an SN1 process 
(Scheme 4).
In attempts to synthetize 3-fluorinated P-amino acids the all- 
m-3-hydroxylatcd amino ester 5 was first saturated to 9 (Fig. 2). 
However, treatment of 9 with either DAST or Deoxofluor did, 
not result in any fluorinated derivative, but only an inseparable 
and unidentified mixture of elimination (detected by ;H NM R of 
the mixture) products (Scheme 3). The reason for this unexpected 
result is not yet known, probably stereochemical aspects contribute 
to this phenomenon.
Fluorination of 6 upon treatment with either DAST or De­
oxofluor gave not the expected 3-fluorinated amino ester (SN2 
product), but the 5-fluorinated 2-aminocyclohexenecarboxylate 10 
(Scheme 5. Fig. 3). This transformation may be explained by attack
This journal is The Royal Society of Chemistry 2011
Scheme 4 Possible route to fluorinated amino esters 7 and 8.
Fig. 2 ORTEP diagram of 9.
C10
Fig. 3 ORTEP diagram of 10.
of the fluoride anion on the sp2 C-atom at position 5 of 6. with 
simultaneous displacement of the hydroxy function according to 
an Sn2' mechanism (Scheme 6).
In contrast with its all-cis counterpart (9) (Scheme 3), fluorina­
tion of 11 in the presence of DAST in CEFCT at 0 : C furnished 
3-fluoro-2-aminocyclohcxanecarboxylate 12 in 43% isolated yield; 
it was separated from the side-product 13 by flash chromatography 
(Scheme 5).
The above-presented synthetic route to fluorinated (3- 
aminocyclohexanecarboxylates could be extended towards the 
synthesis of these compounds in enantiomerically pure form.
Enantiomerically pure amino acid (+)-14 was synthetized 
through CAF-B-catalysed ring cleavage of the corresponding
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Scheme 6 Possible route to fluorinated amino ester 10.
racemic [3-lactam 1. by the method previously described.9 Amino 
acid (+)-14 was converted then (in the same way as for the racemic 
substances) through the corresponding optically pure lactone (+)- 
4 into hydroxylated amino esters (+)-5 and (+)-6 (Scheme 7).
Scheme 7 Synthesis of hydroxylated amino ester enantiomers (+)-5 and 
( + ) - 6 .
Hydroxylated amino ester enantiomer (+)-5 was transformed by 
treatment with DAST, followed by hydrogenation of the obtained 
mixture into optically pure fluorinated aminocarboxylates (-)-7 
and (-)-8 (15% overall yield for the two steps: Scheme 8).









Scheme 8 Synthesis of fluorinated amino ester enantiomers (-)-7 and
H -8.
Fluorination of (+)-6 gave cnantiopurc 5-fluorinated amino 
ester (+)-10. while saturation to (+)-ll, followed by treatment
with DAST. resulted in the enanliomerically pure 3-fluorinated 
aminocarboxylate (-)-12 in 41% yield (Scheme 9).
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Scheme 9 Synthesis of fluorinated amino ester enantiomers (+)-10 and 
(-H 2.
Selective hydroxylation of amino esters permits the synthesis 
of geminal difluorinated amino derivatives via the corresponding 
keto-aminocarboxylates. For this purpose, hydroxy amino esters 9 
and 11 were oxidized with sulfur trioxide-pyridine complex in the 
presence of Et,N, in DMSO to give the corresponding 3-keto-2- 
aminocarboxylates 15 and 16 in good yields (Scheme 10. Fig. 4).
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Scheme 10 Synthesis of difluorinated (3-amino esters 17 and 18.
Fig. 4 ORTEP diagram of 16.
On treatment with Deoxofluor and 1 drop of EtOH in 
CH2C12, amino esters 15 and 16 underwent fluorination involving


































oxo-difluoro exchange to afford the desired difluonnated amino 
esters 17 and 18 in moderate yields (Scheme 10).
Conclusions
In conclusion, a selective approach has been developed for the 
introduction of a fluorine atom onto the cyclohexane ring of 
a cyclic P-amino acid via selective hydroxylation and hydroxy- 
fluorine exchange. This method allowed the synthesis of the 
enantiomers of novel monofluorinated p-aminocarboxylates and 
gcminal difluorinated derivatives.
Experimental section
General procedure for dehydroiodination of iodolactone
DBU (2.1 equiv. 18.9 mmol) was added to a solution of iodolactone 
3 (9 mmol) in THF (40 mL), and the mixture was stirred at 65 °C 
for 4 h. The solution was then concentrated under reduced pressure 
and the residue was extracted with EtOAc (100 mL). The organic 
layer was washed with H :0  (3 x 50 mL). dried (Na:S 0 4) and 
concentrated under vacuum. The residue was crystallized from 
n-hexane-EtOAc, giving a white solid.
rm-Butyl (lR*,55'*,8R*)-7-oxo-6-oxabicyclo[3.2.11oet-3-en-8- 
ylcarbamate (4)
A white solid, mp 146-147 °C. Yield: 80%. (R, 0.45, n-hexane- 
EtOAc 2 : 1). H NM R (400 MHz, DMSO): <5= 1.43 (s, 9H, /Bu), 
2.33-2.41 (m, 1H, C H :), 2.60-2.67 (m, 1H. CH: ). 2.78-2.82 (m, 
1H. H -l), 3.85-3.90 (m, 1H, H-8), 4 .68^ .74  (m. I l l  H-5), 5.88- 
5.95 (m. 1H. H-2). 6.24-6.30 (m. 1H. H-3). 7.58 (brs. 1H. N-H). 
1JC NM R (400 MHz, CDCh): 8  = 28.7. 30.1.44.6. 57.2, 77.6. 81.5, 
128.4, 131.3, 155.4. 172.0. Anal. Calcd. for C 12H I7N 0 4: C, 60.24;
H. 7.16: N, 5.85. Found: C, 60.45; H. 6.90; N. 5.58.
General procedure for ring opening of bicyclic lactone 4
NaOEt (1.2 equiv, 3.6 mmol) was added to a solution of 
unsaturated lactone 4 (3 mmol) in anhydrous EtOH (20 mL) 
at 0 °C, and the reaction mixture was stirred further at the 
temperature and for the lime indicated in the text. The EtOH was 
then removed under reduced pressure at 40 °C and the residue was 
extracted with CH2C12 (40 mL). The organic layer was washed with 
H ;0  (2 x 20 mL). dried (Na2S 0 4) and concentrated under reduced 




A colourless oil. Yield: 75%. (R, 0.45. n-hexane-EtOAc 1:1). 'H 
NM R (400 MHz, DMSO): 8  = 1.19 (t, 3H. C H 3, J  = 7.20 Hz),
I . 38 (s, 9H. /Bu), 2.00-2.08 (m. 1H, C H 2), 2.37-2.44 (m, 1H, CH2), 
2.79-2.88 (m, 1H, H -l), 3.98-4.06 (m. 211. OCH:), 4.15-4.20 (m, 
111. H-2). 4.21-4.27 (m, 1H, H-3), 4.82 (brs, 1H. O-H), 5.38-5.42 
(m. 1H. H-5), 5.58 (brs, 1H, N-H). 5.60-5.64 (m, 1H. 11-4). L’C 
NM R (400 MHz. DMSO): <5 = 14.8, 23.8, 29.0. 40.6, 51.7, 60.6, 
66.9. 78.6. 127.5, 131.8, 156.4, 173.1. Anal. Calcd. for C14H23N 0 5: 
C. 58.93: H. 8.12; N. 4.91. Found: C. 58.65: H. 7.86: N, 5.25.
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A colourless oil. Yield: 68%. (R, 0.40, n-hexane-EtOAc 1:1). H 
NM R (400 MHz, CDCfi): <5 = 1.23 (t, 311. CH,. J  = 7.10 Hz), 1.42 
(s, 9H, /Bu), 2.38-2.43 (m, 1H, CH 2), 2.55-2.60 (m. 1H. CH:), 
2.77-2.82 (m, HI, H -l), 3.99-4.05 (m, 1H, H-2). 4.17-4.22 (m, 
3H. H-3 and OCH;). 5.10 (brs, III, N -H ). 5.82-5.98 (m. 2H. H-4 
and H-5). I3C N M R (400 M Hz, DMSO): 8 =  14.6. 28.6. 28.7.41.3. 
52.5, 61.3. 65.4. 80.5, 127.2, 129.9. 155.6. 172.0. Anal. Calcd. for 
C 14H23N 0 5: C, 58.93: H. 8.12; N, 4.91. Found: C. 58.61; H. 7.80; 
N, 4.60.
General procedure for the reduction of 5 or 6
HCOONHj (8 mmol. 5 equiv) and 10% P d /C  (90 mg) were added 
to a solution of hydroxy amino ester 5 or 6 (1.5 mmol) in EtOH 
(20 mL) and the mixture was stirred at 75 °C. After 1 h the solids 
were filtered off. and the filtrate was concentrated and purified by 
flash chromatography on silica gel (n-hexane-EtOAc 1:1).
Ethyl (lR*,2R*,35'*)-2-(/<.’/7-butoxycarbonylamino)-3- 
hydroxycvclohexanecarboxylate (9)
A white solid, mp 92-95 °C. Yield: 78%. (R, 0.50, n-hexane-EtOAc 
2:1). H NM R (400 MHz, DMSO): 8 =  1.24(t, 3H. CH3, J  = 7.10 
Hz), 1.32-1.40 (m. 1H .C IL ), 1.46 (s. 911./Bu), 1.65-1.78 (m, 5H, 
CH,), 2.88-2.92 (m. HI. II-l), 3.82-3.86 (m. 1H. H-2). 4.02-4,08 
(m, 1H. H-3). 4.13—4.20 (m. 211. OCTL), 5.22 (brs. 1H. N -H ). I3C 
NMR (400 MHz. CDC1,): 8  = 14.5, 18.8, 25.2, 28.7. 31.1. 44.5. 
52.4. 61.5, 70.4. 80.5, 150.2, 170.6. Anal. Calcd. for C u H25N 0 5: 
C, 58.52; H, 8.77: N. 4.87, Found: C. 58.22; H. 8.99; N. 4.53.
Ethyl (lS*,2R*,3S,*)-2-(rerr-butoxycarbonylamino)-3- 
hydroxycyclohexanecarboxylate (11)
A white solid, mp 56-58 °C. Yield: 80%. (R, 0.50. n-hexane- EtOAc 
2:1). 'H  NM R (400 MHz, DMSO): 8  = 1.22 (t, 3H. CH.-„ J  = 
7.15 Hz), 1.41 (s, 911. /Bu), 1.50-1.65 (m, 4H. C H ;). 1.82-1.95 
(m, 2H. CH ;). 2.66-2.73 (m. 111, H -l), 3.73-3.80 (m, 1H, H-2), 
4.08-4.17 (m. 3H. H-3 and OCIL), 5.00 (brs, 1H, N -H ). I3C NM R 
(400 MHz. CDCl-,): <5 = 14.6, 18.5. 28.5. 28.7, 32.0. 44.3. 54.8. 60.9, 
68.9, 80.5, 152.3. 174.6. Anal. Calcd. for C 14H25N 0 5: C. 58.52: II, 
8.77; N, 4.87. Found: C. 58.71; IF 8.49; N. 4.59.
General procedure for reduction of fluorinated amino esters (T1 
and T2) with a cyclohexene skeleton
10% P d /C  (60 mg) was added to a solution of fluorinated amino 
ester mixture (T1 and T2) (1 mmol) in EtOAc (15 ml.) and the 
mixture was stirred under H , at 20 °C. After 1 h the solids were 
filtered off, and the filtrate was concentrated and purified by flash 
chromatography on silica gel (n-hexane-EtOAc 1:1).
General procedure for fluorination
DAST or Deoxofluor in 50% toluene (1.3 equiv) was added at 
0 °C to a solution of hydroxy amino ester 5. 6. 9 or 11 (0.5 mmol) 
in CfLC h (5 mL) under an Ar atmosphere and the solution was 
stirred for the time indicated. The solution was then diluted with 
CH,C1: (20 mL) and the organic layer was washed with saturated
Ethyl (LS'*,2/?*,35'*)-2-(rtTr-butoxycarbonylamino)-3-
hydroxycyclohex-4-enecarboxylate (6)



































aqueous NaHCO, solution ( 2 x 1 5  mL). The organic layer was 
dried (Na2S 04) and concentrated. The crude product was purified 
on flash chromatography on silica gel (n-hexane-EtOAc 9:1).
Ethyl (l/?*,2S'*,5/?*)-2-(/ef7-butoxycarbonylaniino)-5- 
fluorocyclohexanecarboxylatc (7)
A white solid, mp 95-99 °C (n-hexane). Yield: 21% (from 5) (R { 
0.55. n-hexanc-EtOAc 4:1). ‘H NM R (400 MHz. CDC1,): 8 = 
1.27 (t. 3H. CII,. 7 = 7.15 Hz), 1.43 (s, 911, /Bu). 1.59-1.80 (m, 2H, 
CH2), 1.82-2.00 (m ,2H ,C H 2), 2.10-2.21 (m, 1H, CIT), 2.39-2.44 
(m, 1H. CH: ). 2.72-2.77 (m, HI. H -l), 3.82-3.93 (m. 1H. H-2), 
4.16-4.23 (m. 2H. OCH2), 4.62-4.80 (m. IH. H-5). 5.56 (brs, 1H. 
N -H ). r'C  NM R (400 MHz, CDC13): 8  = 14.4. 25.4. 28.8. 29.7,
32.7. 42.1, 48.3, 60.9, 79.9, 87.8. 89.5, 155.2, 172.5. Anal. Calcd. 




A white solid, mp 64-66 °C (n-hexane). Yield: 20% (from 5) (R,- 
0.6. n-hexane-EtOAc4 :1 ) .1H NM R (400 MHz. CDC1,): 8  = 1.20 
(t. 3H. C H „ J  = 7.15 Hz). 1.39 (s. 9H. /Bu). 1.62-2.20 (m, 6H, 
CH;), 2-91-2.99 (m, 1H. H -l). 3.95-4.02 (m. 1H. H-2). 4.04-4.09 
(m, 2H. OCH.). 4.57-4.70 (m, 1H. H-5). 4.99 (brs. 111. N-H). 
15C NMR (400 MHz, CDC1,): 8  = 14.2, 25.6. 25.7. 28.4. 41.5,
44.7, 47.9. 60,8. 79.5. 86.8. 89.1, 155.2, 173.5. Anal. Calcd. for 




A white solid, mp 128-130 °C (n-hexane). Yield: 40% (R, 0.6, n- 
hexane-EtOAc 3:1). 'H  NMR (400 MHz. CDC1,): 8  = 1.24 (t, 
3H, CH-.. J  = 7.15 Hz), 1.46 (s, 9H. /Bu). 2.00-2.10 (m, 1H. CIT), 
2.12-2.18 (m. 1H. CH ;), 2.55-2.71 (m, 1H. H - l). 4.06-1.12 (m, 211, 
OCH;). 4.38—4.46 (m, 1H, 11-2), 4.67 (brs, 1H. N-H). 4.88-5.09(m, 
111. H-5), 5.88-6.00 (m, 211, H-3 and H-4). UC NM R (400 MHz, 
CDClj): 8  = 14.6. 28.7, 31.2, 42.5, 49.5, 61.5, 80.2. 81.9, 84.1,
125.7.135.8. 155.4. 173.4. Anal. Calcd. for C u H:;FNO.: C. 58.52; 
H, 7.72: N, 4.87. Found: C, 58.17; H. 8.03: N. 4.51.
Ethyl (15’*,2/?*,3^*)-2-(/6'j-/-butoxycarbonylamino)-3- 
fluorocyclohexanecarboxylate (12)
A white solid, mp 94-96 °C (n-hexane). Yield: 43% ( R t 0.65, n- 
hexane-EtOAc 3:1). 'H  NM R (400 MHz. DMSO): 8  = 1.23 (t, 
3H. CH 3, J  = 7.15 Hz), 1.32-1.40 (m, 211. CH ; ). 1.41 (s, 9H, 
/Bu). 1.42-1.51 (m. 1H. CIT), 1.60-1.68 (m, 2H. CH: ), 2.02-2.10 
(m, 1H. C H :), 2.40-2.48 (m, 1H. H -l), 3.52-3.57 (m. 1H. H-2), 
3.99-4.09 (m, 2H. OCH:), 4.18-4.46 (m, 1H. H-3), 6.92 (brs, 1H, 
N -H ). 13C NM R (400 MHz, CDC1,): 8  = 14.6, 22.6, 28.7, 30.1,
31.8. 48.1, 56.6, 61.2, 80.8, 89.0, 91.0, 154.5, 170.3. Anal. Calcd. 




A while solid, mp 55-57 °C (n-hexanc). Yield: 20% (R : 0.7. n- 
hcxane-EtO.Ac 3:1). 'H  NM R (400 MHz, CDC1,): 8  = 1.22 (t. 
3H, C H „ /  = 7.15 Hz). 1.42 (s, 9H, /Bu), 1.83-1.90 (m. 2H. C H :), 
2.05-2.10 (m, 2H. CIT), 2.53-2.58 (m. III. H -l), 4.13—4.19 (m, 
2H, OCH;). 4.41-4.47 (m, 1H. H-2). 4.58 (brs, 1H. N -H ), 5.60- 
5.65 (m. 1H. H-4). 5.79-5.86 (m, 1H. H-3). ” C NM R (400 MHz. 
CDClj): 8  = 14.6. 23.9. 24.0. 28.7, 46.5. 48.7. 60.9. 80.7, 128.2. 
129.5, 155.4. 174.2. Anal. Calcd. for C |4H;,N 0 4: C. 62.43: H, 
8.61; N, 5.20. Found: C. 62.08; H, 8.98; N, 4.91.
Characterization of enantiomers
The ec value for (-)-7 was determined by gas chromatography on a 
Chromopack Chiralsil-L-Val column (25 m) {[100 °C for 7 min —> 
190 °C (temperature increase 5 °C min-1); 70 kPa; retention time 
(min): 19.48 (antipode: 19.38). The ec values for (-)-8. (-)-12 and 
(+)-10 were determined by gas chromatography on a Chromopack 
Chirasil-Dex CB column (25 m) {[120 °C for 7 min —> 190 °C 
(temperature increase 5 °C min-1); 70 kPa; retention times (min): 
(-)-8: 20.58 (antipode 20.66), (-)-12: 22.29 (antipode 22.77). (+)- 
10: 22.36 (antipode 22.46).
The NM R spectra o f the enantiomeric compounds were the 
same as those for the racemic compounds.
(l/f,2Y)-2-(/i’j7-Butoxycarbonyhimino)cyclohex-3-cnecarboxylie 
acid |(-)-2|




A white solid, mp 161-163 °C (n-hexane). Yield: 79%. [«][{ = +16 
(c 1.435, EtOH).
/cT/-Butyl (1 /A5/?.8.S')-7-oxo-6-oxabicyclo[3.2.1 |oct-3-en-8- 
ylcarbamate [(-)-4|




A colourless oil. Yield: 68%. [a];,5 = +43.6 (c 0.515. EtOH).
Ethyl (lS’,2/A3S)-2-(Zc'i7-butoxycarbonyIamino)-3-
hydroxycyclohex-4-enecarboxyIatc [(—)-6[
A colourless oil. Yield: 66%. [a]2D5 = +563 (c 0.305. EtOH).
Ethyl (15’,2S,3/?)-2-(/c'j7-butoxycarbonylamino)-3- 
hydroxycyclohcxanecarboxylate |(-)-l 1]
A white solid, mp 55-58 =C. Yield: 83%. [ « £  = +58.4 (c 0.635. 
EtOH).






































A white solid, mp 94-96 °C (n-hexane). Yield: 15% (two steps), 
ee > 98%, [a]~ = -10.8 (c 0.59, EtOH).
Ethyl (1 /?,2S,5S')-2-(/t'i7-butoxycarbonylamino)-5- 
fluorocyclohexanecarboxylate |(-)-8]
A white solid, mp 62-63 °C; (n-hexane); Yield: 15% (two steps), 
ee > 98%, [a];> = -27.5 (c 0.455. EtOH).
Ethyl (15,25',5Y)-2-(?ert-butoxycarbonylamino)-5-fluorocyclohex- 
3-enecarboxvlate |(—)-l0]
A white solid, mp 120-123 °C (n-hexane). Yield: 52%. ee > 98%, 
[a]“  = +39.1 (c 0.405, EtOH).
Ethyl (15,2^,3/f)-2-(iert-butoxycarbonylamino)-3- 
fluorocyclohexanecarboxylate |(-)-12|
A white solid, mp 95-97 °C (n-hexane). Yield: 41%. ee > 98%, 
[a]~ = -7 .1  (c 0.35, EtOH).
General procedure for oxidation of 9 and 11
Sulfur trioxide-pyridine complex (3 equiv) and DMSO (2 mL) and 
Et,N  (4 equiv), were added at 0 °C to a solution of amino ester 9 
or 11 (2 mmol) in CH 2C12 (20 mL) and the mixture was stirred for 
10 h at 20 °C. It was then diluted with C H 2C12 (20 mL), washed 
with H20  (3 x 20 mL), dried over N a2S 0 4 and concentrated. The 
crude product was purified by flash chromatography on silica gel 
(n-hexane-EtOAc 3: 1).
Ethyl (1 /?*,2/?*)-2-(ferif-butoxycarbonylamino)-3- 
oxocyclohexanecarboxylatc (15)
A white solid, mp 60-63 °C; (n-hexane); Yield: 70%; (R, 0.6, n- 
hexane-EtOAc 2: 1).1H N M R (400 MHz, CDCfl): <5- 1.22 (t, 3H, 
C H :, 7 = 7.20 Hz), 1.43 (s, 9H, /Bu), 1.78-1.88 (m, 1H.CIL). 1.97- 
2.22 (m, 3H. C H 2), 2.33-2.40 (1H, C H ;), 2.58-2.63 (m. III. CH2), 
3.78-3.82 (m. 1H. H -l), 4.13^1.18 (m, 2H. OCH2), 4.30-4.36 (m, 
1H. H-2), 5.62 (brs, 1H, N -H ). Anal. Calcd. for C 14H23NOs: C, 
58.93; H, 8.12; N, 4.91. Found: C, 58.61; H. 7.84; N. 4.62.
Ethyl (15’*,2/?*)-2-(te»7-butoxycarbonylamino)-3- 
oxocyclohcxanecarboxylate (16)
A white solid, mp 90-92 °C; (n-hexane); Yield: 74%; (R , 0.55, n- 
hexane-EtOAc 2:1). 'H  NM R (400 MHz, CDC1,): 5 = 1.23 (t, 
3 H ,C H „ 7 = 7.20 Hz), 1.41 (s, 9H, /Bu), 1.59-1.72 (m. 1H. CIL), 
2.07-2.20 (m, 3H, CH2), 2.39-2.58 (m, 3H, CH2 and H -l), 4.09- 
4.20 (m, 2H, OCH2), 4.46-4.52 (m. 1H, H-2), 5.08 (brs, 1H, N-H). 
,?C NM R (400 MHz, CDC13): <5 = 14.5, 25.9, 28.4. 28.6.41.1.52.5, 
60.6, 61.6, 80.2, 155.7, 172.2, 206.1. Anal. Calcd. for C 14H23N 0 5: 
C, 58.93; H, 8.12; N, 4.91. Found: C, 58.66; H. 7.88; N, 4.65.
Ethyl (lS',2S')-2-(tei*r-butoxycarbonylamino)cyclohex-3-
cnccarboxylate |(-)-13|
General procedure for fluorination of keto-amino ester 15 or 16
Dcoxofluor (50% in toluene) and 1 drop of EtOH were added at
0 °C to a solution of amino ester 15 or 16 (1 mmol) in C H 2C12 
(10 mL), and the mixture was stirred at this temperature for 8 h. 
Then the mixture was diluted with C H ;C1: (20 mL) and washed 
with an aqueous solution of N al lCO,. The organic layer was next 
dried over N a2S 0 4 and concentrated, and the crude product was 




A white solid, mp 83-85 °C (n-hexane). Yield: 32% (R , 0.65. n- 
hexane-EtOAc 4 :1). ' l l  N M R (400 MHz, CDC1-,): 8 = 1.23 (t, 
3H, C H 3, 7 = 7.15 Hz), 1.41 (s. 9H, /Bu), 1.58-1.70 (m. 1H .C H :), 
2.04-2.20 (m, 3H. CH2), 2.41-2.59 (m. 3H, CIT and H-l). 4.07- 
4.20(m, 2H. OCH2), 4.44-4.53 (m, III. H-2), 5.09 (brs, 1H. N-H). 
Anal. Calcd. for C 14H23F2N 0 4: C, 54.71; H, 7.54; N. 4.56. Found: 
C, 54.43; H, 7.29; N, 4.27.
Ethyl (lY*,2/?*)-2-(riTr-butoxycarbonylainino)-3,3- 
difluorocyclohexanecarboxylate (18)
A white solid, mp 88-90 °C (n-hexane). Yield: 39% (R , 0.60. n- 
hexanc-EtOAc 4 :1). 'H  NM R (400 MHz, CDC13): 0 = 1 .2 2  (t. 
311. CH-„ 7 = 7.15 Hz). 8  = 1.40 (s, 9H. /Bu). 1.46-1.73 (m. 3H, 
CH;), 1.78-1.84 (m, 1H ,C H 2), 1.93-2.00 (m, 1H, CH; ). 2.17-2.23 
(m, 1H. CH2), 2.41-2.50 (m, III, H -l), 4.09-4.21 (m, 3H. OCH2 
and H-2), 4.71 (brs. 1H. N -H ). Anal. Calcd. for C 14H23F2N 0 4: C, 
54.71; H, 7.54; N. 4.56. Found: C, 54.46; H, 7.20; N. 4.23.
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